Inventor · disambiguated record
Julie Marie Hicks
Also filed as: HICKS JULIE MARIE
5 granted patents·2 pending applications·20 citations·filing 2013–2022
73Inventor score
Files withARRAY BIOPHARMA INC7
Top patents by PatentIndex Score
7 records- 0193US10780073B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·7 cites·24 claims
- 0291US9693989B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2013·Granted Jul 4, 2017·13 cites·28 claims
- 0381US12171739B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 0471US2021008023A1N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 0560US2017252317A1N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 0650US8895550B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·0 cites·22 claims
- 0744US8987251B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Mar 24, 2015·0 cites·33 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →